Jeff Yass’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.43M Buy
72,200
+30,100
+71% +$1.96M ﹤0.01% 3881
2026
Q1
$2M Sell
42,100
-22,700
-35% -$1.02M ﹤0.01% 6180
2025
Q4
$2.06M Buy
64,800
+26,700
+70% +$833K ﹤0.01% 5606
2025
Q3
$1.07M Buy
38,100
+12,400
+48% +$376K ﹤0.01% 7199
2025
Q2
$946K Buy
25,700
+8,300
+48% +$287K ﹤0.01% 7576
2025
Q1
$683K Sell
17,400
-6,500
-27% -$293K ﹤0.01% 8203
2024
Q4
$1.11M Sell
23,900
-12,200
-34% -$551K ﹤0.01% 6689
2024
Q3
$1.63M Sell
36,100
-57,400
-61% -$2.73M ﹤0.01% 5715
2024
Q2
$4.61M Sell
93,500
-53,200
-36% -$2.17M ﹤0.01% 3575
2024
Q1
$5.03M Sell
146,700
-71,000
-33% -$2.56M ﹤0.01% 3627
2023
Q4
$8.02M Buy
217,700
+95,200
+78% +$2.2M ﹤0.01% 2948
2023
Q3
$2.48M Buy
122,500
+50,700
+71% +$1.11M ﹤0.01% 4722
2023
Q2
$1.47M Buy
71,800
+42,900
+148% +$643K ﹤0.01% 5815
2023
Q1
$436K Sell
28,900
-2,700
-9% -$59.6K ﹤0.01% 8896
2022
Q4
$752K Buy
31,600
+22,000
+229% +$638K ﹤0.01% 6818
2022
Q3
$338K Sell
9,600
-20,800
-68% -$883K ﹤0.01% 9485
2022
Q2
$1.06M Sell
30,400
-2,700
-8% -$95.6K ﹤0.01% 6376
2022
Q1
$1.63M Sell
33,100
-66,800
-67% -$3.7M ﹤0.01% 5932
2021
Q4
$7.73M Buy
99,900
+31,300
+46% +$3.21M ﹤0.01% 3067
2021
Q3
$7.34M Sell
68,600
-16,100
-19% -$1.84M ﹤0.01% 3329
2021
Q2
$11.3M Buy
84,700
+18,900
+29% +$2.2M ﹤0.01% 2743
2021
Q1
$8.15M Sell
65,800
-900
-1% -$137K ﹤0.01% 3109
2020
Q4
$9.42M Buy
66,700
+14,300
+27% +$1.59M ﹤0.01% 2576
2020
Q3
$3.98M Buy
52,400
+40,000
+323% +$2.49M ﹤0.01% 3379
2020
Q2
$562K Buy
+12,400
New +$445K ﹤0.01% 7128

Other funds holding TWST

Jeff Yass's TWST Position: Q2 2026 in Review

Jeff Yass reduced its Twist Bioscience (TWST) stake by 64% in Q2 2026, selling an estimated $3.74M and leaving 32,880 shares worth $3.38M. The position accounts for ﹤0.01% of the portfolio, ranked #5385.

Jeff Yass first reported a position in TWST in Q2 2019 and has held it in 28 quarters since. The position peaked at $7.37M in Q4 2020. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Jeff Yass held 32,880 shares of Twist Bioscience worth $3.38M as of Q2 2026.
  • Jeff Yass sold 57,439 Twist Bioscience shares in Q2 2026, an estimated $3.74M.
  • Twist Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5385 holding.
  • Jeff Yass first reported a position in Twist Bioscience in Q2 2019 and has held it in 28 quarters since.
  • Jeff Yass's Twist Bioscience position peaked at $7.37M in Q4 2020.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.